2. Immunology/Inflammation Vitamin D Related/Nuclear Receptor Anti-infection Autophagy
  3. Glucocorticoid Receptor SARS-CoV Autophagy Complement System Mitophagy Bacterial Antibiotic
  4. Dexamethasone (Water Soluble)

Dexamethasone (Water Soluble)  (Synonyms: Dexamethasone cyclodextrin complex)

Cat. No.: HY-14648C Purity: ≥98.0%
COA
SDS
Handling Instructions Technical Support

Dexamethasone (Hexadecadrol) Water Soluble is a water-soluble form of Dexamethasone (HY-14648). Dexamethasone is a glucocorticoid receptor agonist, apoptosis inducer, and a common disease inducer in experimental animals. It can be used to construct models of muscle atrophy, hypertension, and depression. Dexamethasone can inhibit the production of inflammatory miRNA-155 exosomes in macrophages and significantly reduce the expression of inflammatory factors in neutrophils and monocytes. Dexamethasone also has the potential to be used in COVID-19 research.(Sale size is the weight of dexamethasone)

For research use only. We do not sell to patients.

Dexamethasone (Water Soluble) Chemical Structure

Dexamethasone (Water Soluble) Chemical Structure

CAS No. : 50-02-2

Size Price Stock Quantity
Free Sample (0.1 - 0.2 mg)   Apply Now  
25 mg In-stock
50 mg In-stock
100 mg In-stock
500 mg In-stock
1 g In-stock
5 g In-stock
10 g Get quote
50 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Dexamethasone (Water Soluble):

Dexamethasone (Water Soluble) Related Antibodies

Top Publications Citing Use of Products

View All Antibiotic Isoform Specific Products:

View All Isoforms
Aminoglycoside Glycopeptide Lipopeptide Macrolide Oxazolidinone Quinolone Tetracycline β-lactam

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Dexamethasone (Hexadecadrol) Water Soluble is a water-soluble form of Dexamethasone (HY-14648). Dexamethasone is a glucocorticoid receptor agonist, apoptosis inducer, and a common disease inducer in experimental animals. It can be used to construct models of muscle atrophy, hypertension, and depression. Dexamethasone can inhibit the production of inflammatory miRNA-155 exosomes in macrophages and significantly reduce the expression of inflammatory factors in neutrophils and monocytes. Dexamethasone also has the potential to be used in COVID-19 research[1].(Sale size is the weight of dexamethasone)

In Vitro

Note:
Product is approximately 65 mg of Dexamethasone per gram containing a balance of β-Cyclodextrin. Solubility in H2O: ≥ 100 mg/mL indicates that 100 mg of the weighed total product (not the effective weight) dissolves in 1 mL of water.

Dexamethasone (Hexadecadrol) regulates several transcription factors, including activator protein-1, nuclear factor-AT, and nuclear factor-kB, leading to the activation and repression of key genes involved in the inflammatory response[1].
Dexamethasone potently inhibits granulocyte-macrophage colony stimulating factor (GM-CSF) release from A549 cells with EC50 of 2.2 nM. Dexamethasone (EC50=36 nM) induces transcription of the β2-receptor is found to correlate with glucocorticoid receptor (GR) DNA binding and occurred at 10-100 fold higher concentrations than the inhibition of GM-CSF release. Dexamethasone (IC50=0.5 nM) inhibits a 3×κB (NF-κB, IκBα, and I-κBβ), which is associated with inhibition of GM-CSF release[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Dexamethasone (Water Soluble) Related Antibodies
In Vivo

Based on blood and multi-tissue concentration-time profiles of Dexamethasone (DEX), no significant sex differences were found in its tissue distribution. Blood cell to plasma partitioning (0.664) and plasma free fraction (0.175) were moderate, with widespread distribution in the liver (Kp=6.76). Possibly due to P-glycoprotein-mediated efflux, the concentration of DEX in the brain is very low compared to the expected high permeability[5].
Dexamethasone (DEX) can be used in animal modeling to construct models of muscle atrophy, hypertension and depression.

1. Induction of muscle atrophy[6][7]
Background
Glucocorticoids are important mediators of skeletal muscle protein degradation and upregulation of the ubiquitin-proteasome pathway. Dexamethasone induces tibialis anterior muscle protein degradation by binding to the glucocorticoid receptor, resulting in muscle atrophy.
Specific Modeling Methods
Mice: C57BL/6 • male • 6-week-old
Administration: 5 mg/kg • ip • once daily for 2 weeks
Modeling Indicators
Molecular changes: Increased indicators: C2C12 ubiquitin ligase, MuRF1, Atrogin-1, Cbl-b, p-Foxo1, p-Foxo3a. Resulted C2C12 myotube protein degradation, and Glucocorticoid receptor translocation to the nucleus
Phenotypic observation: Decreased indicators: The weight of the anterior muscles, gastrocnemius, quadriceps and soleus muscles. The ratio of skeletal muscle to body weight decreases.
Correlated Product(s): Betamethasone (HY-13570)
Opposite Product(s): Glabridin (HY-N0393)
2. Induction of hypertension[8][9]
Background
The underlying mechanisms that induce hypertension (HT) are unknown.
Specific Modeling Methods
Rat: Sprague-Dawley • Male • 200-300 g
Administration: 20 μg • sc • once daily from days 5 to 16 • control rats: saline with 0.1 mL/100 g/day from days 1 to 16 (po) or 0.2 mL/rat/day (sc).
Dog: 10.1-19.1 kg • average=13.7 kg
Administration: 0.5 mg/kg • po • once daily for 10 days
Modeling Indicators
Hemodynamics: MAP, systolic blood pressure, diastolic blood pressure, TPR levels increased in central hemodynamics. Total peripheral resistance, blood pressure, atrial natriuretic peptide, and the pressor response to norepinephrine, are significantly increased in Systemic and renal hemodynamics.
Behavior: The dog showed obvious natriuresis and diuresis.
Opposite Product(s): Saralasin (HY-P0205); Prazosin (HY-B0193)
3. Induction of depressive behavior[10][11]
Background
Astrocytes are a key feature of major depressive disorder (MD), and reduced expression by glucocorticoids results in reduced astrocyte numbers. Long-term treatment with Dexamethasone can cause a series of depression-like symptoms in rodents.
Specific Modeling Methods
Rat: Sprague-Dawley • Male • 200-250 g
Administration: 1 mg/kg • po • once daily every other day for 5 months
Note
(1) Prepare a 3% (w/v) treatment solution and filter through a 0.45 μm cellulose acetate filter.
(2) Rats should not be exposed to any other water source for 4 days before starting treatment.
(3) On the 4th day, change the treatment solution to water and feed for 3 days to allow the mice to recover temporarily. Weigh and conduct behavioral experiments on day 7.
Mice: C57BL/6 • Male • 9-10 weeks old • 23-25 g
Administration: 4 mg/kg • ip • once dailly for 21 days
Modeling Indicators
Metabolism changes: Serum cortisol levels in rats ↑.
Behavior: Immobility time during the forced swim test (FST) &uarr. Preference for sucrose &darr in the sucrose preference test.
Opposite Product(s): Amitriptyline (HY-B0527)

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
CAS No.
Appearance

Solid

Color

Off-white to light yellow

SMILES

[Dexamethasone (Water Soluble)]
Shipping

Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

H2O : ≥ 100 mg/mL

*"≥" means soluble, but saturation unknown.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Dexamethasone (Water Soluble) Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Dexamethasone (Water Soluble)50-02-2Dexamethasone cyclodextrin complexGlucocorticoid ReceptorSARS-CoVAutophagyComplement SystemMitophagyBacterialAntibioticSARS coronavirusMitochondrial AutophagyInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Dexamethasone (Water Soluble)
Cat. No.:
HY-14648C
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (251 KB) Français - FR (251 KB) Deutsch - DE (251 KB) Norwegian - NO (251 KB) Español - ES (251 KB) Swedish - SV (251 KB) Italian - IT (251 KB) Portuguese - PT (251 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.